Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201822 · ClinicalTrials.gov registry record · NA
Intake-dependent Effect of Cocoa Flavanol Absorption, Metabolism and Excretion in Humans
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03201822 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 14 participants.
The verdict
NCT03201822, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
A randomized, double-masked and cross-over dietary intervention study in healthy young adult males to evaluate the concentration of F-derived metabolites in plasma and urine after single acute intakes of F-containing drinks on four different test days.
Interventions
- OTHER 100 mg of Cocoa Flavanols/70 kg BW
- OTHER 200 mg of Cocoa Flavanols/70 kg BW
- OTHER 400 mg of Cocoa Flavanols/70 kg BW
- OTHER 1000 mg of Cocoa Flavanols/70 kg BW
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-04-01 |
| Est. Completion | 2013-05-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03201822
The ClinicalTrials.gov registry entry for NCT03201822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which 100 mg of Cocoa Flavanols/70 kg BW is the first listed.
NCT03201822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03201822 about?
NCT03201822 is a clinical study titled "Intake-dependent Effect of Cocoa Flavanol Absorption, Metabolism and Excretion in Humans". A randomized, double-masked and cross-over dietary intervention study in healthy young adult males to evaluate the concentration of F-derived metabolites in plasma and urine after single acute intakes of F-containing drinks on four different test days.
What is the current status of trial NCT03201822?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2013-04-01. Estimated completion is 2013-05-25.
What interventions are being tested in trial NCT03201822?
The interventions under investigation include: 100 mg of Cocoa Flavanols/70 kg BW (OTHER), 200 mg of Cocoa Flavanols/70 kg BW (OTHER), 400 mg of Cocoa Flavanols/70 kg BW (OTHER), 1000 mg of Cocoa Flavanols/70 kg BW (OTHER).
Who is sponsoring clinical trial NCT03201822?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.